Oncologist voices caution on EGFR inhibitors in bowel cancer
21 July 2010
| by Laura Macfarlane
A Sydney-based oncologist has voiced caution when considering the effectiveness of epidermal growth factor receptor (EGFR) inhibiting drugs on some forms of bowel cancer at the Sydney Cancer Conference this week....
Want to read complete article? Please Sign in or Register.